Company intelligence / Profile preview

Osato International

Ono-cho, Gifu, Japan

Ownership: Private
Development stage: Other

Overview

Osato International's Immun'Âge (FPP) has been on the market for over two decades, with extensive use worldwide and clinical data supporting its antioxidative and immunostimulating benefits; Health Canada and FDA recognize its safety as a natural food product

Therapeutic areas: ImmunologyMetabolic DisordersPsychiatryOther
Modalities: Food supplement (Fermented Papaya Preparation)Nutraceutical
Industry: Food & Nutrition

Partnerships

Collaborations with universities and institutes in the U.S., Europe, and Japan for research

Beyond the preview

Go deeper on Osato International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osato International.

Explore the full profile